132 related articles for article (PubMed ID: 6278187)
1. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. I. Isolation, characterization, cell surface markers, and B-cell markers.
Zeuthen J; Klein G; Ber R; Masucci G; Bisballe S; Povey S; Terasaki P; Ralph P
J Natl Cancer Inst; 1982 Feb; 68(2):179-95. PubMed ID: 6278187
[TBL] [Abstract][Full Text] [Related]
2. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
[TBL] [Abstract][Full Text] [Related]
3. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
Klein G; Zeuthen J; Ber R; Ernberg I
J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
[TBL] [Abstract][Full Text] [Related]
4. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
[TBL] [Abstract][Full Text] [Related]
5. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
[TBL] [Abstract][Full Text] [Related]
6. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
7. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
8. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
[TBL] [Abstract][Full Text] [Related]
9. Somatic cell hybrids between human lymphoma lines. III. Surface markers.
Klein G; Terasaki P; Billing R; Honig R; Jondal M; Rosén A; Zeuthen J; Clements G
Int J Cancer; 1977 Jan; 19(1):66-76. PubMed ID: 319066
[TBL] [Abstract][Full Text] [Related]
10. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
[TBL] [Abstract][Full Text] [Related]
11. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
Yamamoto N; Mitsuma T; Vogt A
J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
[TBL] [Abstract][Full Text] [Related]
13. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
14. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
Moar MH; Ber R; Klein G; Westman A; Eriksson I
Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
[TBL] [Abstract][Full Text] [Related]
15. Surface receptors on human haematopoietic cell lines.
Huber C; Sundström C; Nilsson K; Wigzell H
Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
[TBL] [Abstract][Full Text] [Related]
16. Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle.
Klein G; Clements G; Zeuthen J; Westman A
Int J Cancer; 1976 Jun; 17(6):715-24. PubMed ID: 59708
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on the expression of Fc-receptors, Ia antigens, and beta 2-microglobulin following in vitro herpes simplex virus infection of human lymphoid cells.
Dorval G; Bourkas AE; Menezes J
Clin Exp Immunol; 1979 Sep; 37(3):477-85. PubMed ID: 92381
[TBL] [Abstract][Full Text] [Related]
18. Immunological properties of lymphoblastoid cell lines (UHKT) - 1, 2, 3, 4, 5, 6) established from cases of human leukemias.
Koubek K; Stockbauer P; Herzog P; Roubal J; Praehová K; Cinátl J; Korínková P; Michalová K
Czech Med; 1983; 6(3):159-68. PubMed ID: 6315324
[TBL] [Abstract][Full Text] [Related]
19. Contrasting effects of hydroxyurea on cell growth and reduction in Epstein-Barr virus genomes in EBV-infected epithelioid cell lines vs Burkitt's lymphoma cell lines.
Jiang R; Kanamori M; Satoh Y; Fukuda M; Ikuta K; Murakami M; Sairenji T
J Med Virol; 2003 Jun; 70(2):244-52. PubMed ID: 12696111
[TBL] [Abstract][Full Text] [Related]
20. Expression of human CD antigens, including CD1 and CD25, by human x mouse interlineage leukaemia hybrids.
Taylor GM; Morten H; Carr T; Harrison C; Ridway J; Morris Jones P
Immunology; 1987 Dec; 62(4):557-65. PubMed ID: 3428925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]